trending Market Intelligence /marketintelligence/en/news-insights/trending/xyh4trlumseaqfcbujfcsq2 content esgSubNav
In This List

Acceleron Pharma appoints chief business officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Acceleron Pharma appoints chief business officer

Acceleron Pharma Inc. promoted John Quisel to the position of executive vice president, chief business officer and secretary, effective May 10.

Quisel previously served as the company's senior vice president of corporate development, general counsel and secretary.

The Cambridge, Mass.-based clinical-stage biopharmaceutical company is focused on developing therapies for serious and rare diseases.